• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Recalls

B. Braun recalls some two-piece syringes due to potential packaging barrier damage

July 26, 2023 By Sean Whooley

B. Braun Injekt syringes

B. Braun issued an urgent field safety notice in Europe related to potential issues with certain two-piece syringes. The company’s notice said it decided to proactively recall a batch combination of the syringes. B. Braun identified a number of batches of its Exadoral, Henke-JECT, Norm-Ject and Injekt devices. In the course of postmarket surveillance and […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Recalls, Regulatory/Compliance Tagged With: B. Braun

ICU Medical recalls certain infusion pump replacement batteries

May 23, 2023 By Sean Whooley

ICU Medical Plum 360 infusion system

The FDA issued a notice determining that the recall of ICU Medical (Nasdaq:ICUI) infusion pump batteries is Class I, the most serious kind. ICU Medical initiated a recall of replacement batteries for certain infusion systems on March 22, 2023. The recall affects its Plum 360, Plum A+ and Plum A+3 infusion systems. The infusion systems […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Recalls, Regulatory/Compliance Tagged With: FDA, ICU Medical

Medtronic Diabetes unit fully resolves FDA warning letter

April 25, 2023 By Sean Whooley

Medtronic World Diabetes Day

Medtronic (NYSE:MDT) announced today that the FDA lifted the warning letter related to its Diabetes business unit headquarters. In December 2021, the FDA issued a warning letter to Medtronic’s Northridge, California, Diabetes headquarters. The letter centered around the inadequacy of specific medical device quality system requirements at the Northridge facility. It scrutinized the areas of […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Recalls, Regulatory/Compliance, Technology Tagged With: FDA, Medtronic

Abbott FreeStyle Libre reader warning affects more than 4 million devices

April 6, 2023 By Sean Whooley

Abbott FreeStyle Libre reader

The FDA today issued a notice classifying a recall of Abbott (NYSE:ABT) FreeStyle Libre readers as Class I, the most serious kind. Earlier this week, Abbott initiated a voluntary medical device correction to emphasize instructions for FreeStyle Libre continuous glucose monitor (CGM) readers. The company said it received a limited number of global reports (0.0017%) from […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Patient Monitoring, Recalls, Regulatory/Compliance, Technology Tagged With: abbott, FDA

Abbott warns on some FreeStyle Libre readers due to battery issues

April 4, 2023 By Sean Whooley

Abbott FreeStyle Libre reader

Abbott (NYSE:ABT) initiated a voluntary medical device correction to emphasize instructions for FreeStyle Libre continuous glucose monitor (CGM) readers. The instructions cover the FreeStyle Libre, Libre 14-day and Libre 2 readers in the U.S. Abbott received a limited number of global reports (0.0017%) from users over several years saying their reader’s lithium-ion battery swelled or […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Patient Monitoring, Recalls Tagged With: abbott, FDA

iRadimed issues urgent field safety notice for some infusion pump syringe adapters

February 27, 2023 By Sean Whooley

Iradimed

iRadimed (Nasadq:IRMD) issued an urgent medical device correction letter to warn of issues with some infusion pump syringe adapter sets. The letter notifies customers of a potential issue with some 1057 Syringe Adapter Sets. The issue relates to the syringe venting function during use. This can lead to reduced flow with the MRidium infusion pump, […]

Filed Under: Business/Financial News, Drug-Device Combinations, Recalls, Regulatory/Compliance, Technology Tagged With: Iradimed

BD issues vulnerability warning for Alaris infusion monitoring software

February 16, 2023 By Sean Whooley

BD Alaris Infusion Central software

BD (NYSE:BDX) today issued a voluntary notification regarding cybersecurity vulnerabilities with its Alaris Infusion Central software. Alaris Infusion Central, a standalone software — separate from pumps — provides data from the Alaris pumps. It allows healthcare providers to monitor infusion data sent from Alaris Plus and Alaris neXus pumps on a computer. Alaris Infusion Central […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Recalls, Regulatory/Compliance Tagged With: Alaris, BD

The 10 biggest diabetes tech stories from 2022

December 27, 2022 By Sean Whooley

Diabetes stories 2022 insulet dexcom abbott senseonics

2022 represented a landmark year for next-generation diabetes tech. Here are the biggest stories from the past year. Some companies picked up major regulatory nods. Others experienced major regulatory setbacks. Partnerships were formed and ended, while mergers and acquisitions came and went. There were many stories to choose from in the world of diabetes tech, […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Patient Monitoring, Recalls, Regulatory/Compliance, Technology, Wall Street Beat Tagged With: abbott, BD, CamDiab, Dexcom, embecta, Insulet, Medtronic, Senseonics, Sernova Inc, Tandem Diabetes Care, Ypsomed

Smiths Medical issues urgent device correction for some CADD infusion pumps

December 12, 2022 By Sean Whooley

Smiths Medical

Smiths Medical today issued an urgent medical device correction letter to inform customers of potential issues with its CADD infusion system. The company — which ICU Medical acquired in January for $2.35 billion — identified two potential issues with the infusion sets. They relate to the potential lack of delivery or underdelivery and false no […]

Filed Under: Drug-Device Combinations, Featured, Recalls, Regulatory/Compliance Tagged With: ICU Medical, Smiths Medical

FDA says Insulet Omnipod Dash batteries recall is Class I

November 17, 2022 By Chris Newmarker

Insulet Ominipod Dash Personal Diabetes Managers

The FDA has posted a notice that an Insulet recall related to Omnipod Dash batteries is Class I, its most serious level. Insulet recently issued a voluntary global safety notice to warn about battery problems. The Omnipod Dash is Insulet’s previous-generation insulin pump. The company since launched its FDA-cleared and CE-marked Omnipod 5 next-generation automated insulin delivery system. The […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Recalls Tagged With: FDA, Insulet

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Interim pages omitted …
  • Page 12
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS